| DC Field | Value | Language |
|---|
| dc.contributor.author | Balanețchi, Ludmila | - |
| dc.contributor.author | Șciuca, Svetlana | - |
| dc.date.accessioned | 2023-07-28T12:13:28Z | - |
| dc.date.available | 2023-07-28T12:13:28Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.isbn | 978-9975-82-328-9 | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/25188 | - |
| dc.description.abstract | Pulmonary infections will remain the major prognostic problem in cystic fibrosis. COVID-19 is a
highly dangerous pathogen for CF. Studies in Europe reported a 0,3% incidence of COVID-19 in CF.
The pathogenesis of SARS-CoV-2 is directly intertwined and overlaps with that of CF. CF patients
infected with COVID-19 would be at high risk of disease, with a more pronounced proinflammatory
response and lung damage. There are no specific protocols for the management of CF patients with
COVID-19. Vaccination against COVID-19 is encouraged. Scientific results show a relatively good
recovery from COVID-19 in CF patients, the disease has similar manifestations to the general
population. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | CEP Medicina | en_US |
| dc.relation.ispartof | Culegerea de lucrări a Conferinței cu participare internațională „Actualități în pneumologia copilului”, 22 iunie 2023, Chișinău, Republica Moldova | en_US |
| dc.title | Impactul infecției COVID-19 asupra afectării pulmonare la copilul cu fibroză chistică | en_US |
| dc.title.alternative | Impact of COVID-19 infection on lung illness in children with cystic fibrosis | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Culegerea de lucrări a Conferinței cu participare internațională „Actualități în pneumologia copilului”
|
